JSC “Pharmstandard” informs about the change to the membership of the Company's management and the appointment of Dmitry Ivanovich Zaytsev as Chief Executive Officer.
Potapov...
The Ministry of Health of the Russian Federation has authorized the first Russian originator for the treatment of multiple sclerosis developed by the scientists of...
On March 19, Algeria released the first batch of insulins from GEROPHARM pharmaceutical substance. The launch of production took place at the plant of...
Co-founder of Nanolek Vladimir Khristenko announced his intention to step down as President, the post he has been holding since 2015. Mr. Khristenko transferred...
NPO Microgen, a company of the Naimbio holding, is launching on the market the first domestic human normal immunoglobulin for intravenous administration in the...
The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles.
According to Nail Nizamutdinov, General...